Published in Cancer on August 15, 2006
Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation. Am J Surg Pathol (2009) 2.32
Laparoscopic partial cystectomy for urachal and bladder cancer. Clinics (Sao Paulo) (2008) 1.07
Urachal carcinoma: a pathologic and clinical study of 46 cases. Hum Pathol (2015) 1.04
A case of metastatic urachal adenocarcinoma treated with several different chemotherapeutic regimens. Can Urol Assoc J (2012) 1.03
Urachal adenocarcinoma masquerading as an urachal cyst. Indian J Surg (2008) 0.93
Urachal carcinoma: imaging findings. Acta Radiol Short Rep (2012) 0.93
Urachal tumour: case report of a poorly understood carcinoma. World J Surg Oncol (2009) 0.92
Investigating urachal carcinoma for more than 15 years. Oncol Lett (2014) 0.91
Synchronous urothelial carcinoma of the bladder and urachal adenoma with subsequent malignant transformation. Korean J Urol (2012) 0.86
Treatment of metastatic urachal adenocarcinoma in a young woman: a case report. Cases J (2009) 0.85
Prognostic factors for urachal cancer: a bayesian model-averaging approach. Korean J Urol (2014) 0.83
Urachal tumour: clinical and radiological features of a poorly understood carcinoma. Ann R Coll Surg Engl (2007) 0.82
Combined modalities treatment of pulmonary metastasis from an urachal adenocarcinoma. Rare Tumors (2013) 0.82
Evaluation and treatment of an unusual urachal mass: a case report. Springerplus (2015) 0.82
Clinical outcome of urachal cancer in Japanese patients. Int J Clin Oncol (2015) 0.80
Response to targeted therapy in urachal adenocarcinoma. Rare Tumors (2014) 0.79
Brain metastasis from urachal carcinoma: the importance of locally aggressive treatment. Rare Tumors (2012) 0.79
Urachal neoplasia: a case report. Radiol Bras (2015) 0.79
En Bloc Robot-assisted Laparoscopic Partial Cystectomy, Urachal Resection, and Pelvic Lymphadenectomy for Urachal Adenocarcinoma. Rev Urol (2015) 0.78
Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations. Oncotarget (2016) 0.76
Fine Needle Aspiration Cytology Diagnosis of an Urachal Adenocarcinoma. J Clin Diagn Res (2016) 0.75
Robot-assisted partial cystectomy with intraoperative frozen section examination: Evolution and evaluation of a novel technique. Investig Clin Urol (2016) 0.75
Urachal adenocarcinoma that metastasized to breast was misinterpreted as primary breast mucinous carcinoma: A rare case report and literature review. Medicine (Baltimore) (2016) 0.75
Urachal carcinoma: Report of two cases and review of the literature. Mol Clin Oncol (2016) 0.75
Urachal cancer with direct caecal invasion: differential diagnosis from primary colon cancer. BMJ Case Rep (2014) 0.75
Infected urachal cyst in a young adult. Cent European J Urol (2014) 0.75
Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance. Oncotarget (2016) 0.75
Clinical comparison of patients with benign urachal masses versus urachal carcinomas. Chin J Cancer (2017) 0.75
Urachal Tumor: A Case Report of an Extremely Rare Carcinoma. Case Rep Pathol (2017) 0.75
Surgical treatment of recurrent urachal carcinoma with liver metastasis: a case report and literature review. World J Surg Oncol (2016) 0.75
An unusual long-term survey of a patient with widespread malignant urachal tumor, not given chemotherapy or radiotherapy. Case Rep Radiol (2015) 0.75
Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease? Transl Androl Urol (2016) 0.75
Extended partial cystectomy with augmentation cystoplasty in urachal adenocarcinoma: An oncologically favorable but underutilized alternative to radical cystectomy. Urol Ann (2016) 0.75
Angiomatous leiomyoma of the urachus: A rare entity masquerading as extraluminal gastrointestinal stromal tumor. Urol Ann (2013) 0.75
National Incidence, Management and Survival of Urachal Carcinoma. Rare Tumors (2016) 0.75
Non-invasive, low-grade papillary urothelial carcinoma in the urachus. BMJ Case Rep (2013) 0.75
Urachal adenocarcinoma: a rare case report. Radiol Case Rep (2016) 0.75
"Look Before You Leap": Urachal Mass in Adults. World J Oncol (2017) 0.75
Intra-abdominal mucinous adenocarcinoma of urachal origin: report of a case. Surg Today (2013) 0.75
Guideline for management of the clinical T1 renal mass. J Urol (2009) 8.26
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res (2006) 8.21
Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol (2008) 5.30
Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol (2007) 5.24
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. Proc Natl Acad Sci U S A (2004) 5.13
Pelvic lymph node dissection in prostate cancer. Eur Urol (2009) 3.93
Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol (2004) 3.92
Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol (2010) 3.71
Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol (2003) 3.66
Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. J Clin Oncol (2007) 3.50
Solid renal tumors: an analysis of pathological features related to tumor size. J Urol (2003) 3.48
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer (2003) 3.33
Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res (2003) 3.25
PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma. Clin Cancer Res (2007) 3.23
Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol (2010) 3.06
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med (2015) 3.00
Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol (2012) 2.73
Robotic-assisted laparoscopic partial nephrectomy: technique and initial clinical experience with DaVinci robotic system. Urology (2004) 2.68
Thromboembolism and bleeding in bladder cancer. Oncology (Williston Park) (2014) 2.66
Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur Urol (2011) 2.63
Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol (2004) 2.61
The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era. J Urol (2010) 2.60
Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer. Cancer (2011) 2.58
Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res (2007) 2.56
Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Eur Urol (2012) 2.52
Bladder cancer. J Natl Compr Canc Netw (2013) 2.46
Treatment of patients with small renal masses: a survey of the American Urological Association. J Urol (2010) 2.45
The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. Eur Urol (2008) 2.40
Comparison of warm ischemia versus no ischemia during partial nephrectomy on a solitary kidney. Eur Urol (2010) 2.38
Radiation therapy after radical prostatectomy: impact on metastasis and survival. J Urol (2009) 2.37
The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional study. J Urol (2007) 2.36
Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology (2012) 2.35
Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence. Eur Urol (2011) 2.33
Comparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer-susceptibility Loci. Am J Hum Genet (2004) 2.31
Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy. Clin Cancer Res (2007) 2.26
B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. Proc Natl Acad Sci U S A (2006) 2.24
Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery (2008) 2.23
A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol (2004) 2.23
The effect of benign lower urinary tract symptoms on subsequent prostate cancer testing and diagnosis. Eur Urol (2013) 2.19
B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. Cancer Res (2007) 2.19
Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol (2007) 2.12
Complications of contemporary open nephron sparing surgery: a single institution experience. J Urol (2005) 2.10
Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol (2004) 2.08
Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J Urol (2009) 2.05
Significance of distal ureteral margin at radical cystectomy for urothelial carcinoma. J Urol (2010) 2.05
Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer. J Urol (2005) 2.01
PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression. Cancer (2007) 2.00
Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma. Cancer (2009) 2.00
The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int (2004) 2.00
Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int (2005) 2.00
Urachal anomalies: a longitudinal study of urachal remnants in children and adults. J Urol (2007) 1.99
Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. Clin Cancer Res (2008) 1.97
Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet (2003) 1.96
Tumor B7-H1 and B7-H3 expression in squamous cell carcinoma of the lung. Clin Lung Cancer (2012) 1.93
Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol (2010) 1.93